12.07.2015 Views

Badan Pengawas Obat dan Makanan Republik Indonesia ...

Badan Pengawas Obat dan Makanan Republik Indonesia ...

Badan Pengawas Obat dan Makanan Republik Indonesia ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Suplemen Bab 1 – Manajemen Mutu Supplement Chapter 1 – Quality Managementpengemasan <strong>dan</strong> pengujian bets,dilakukan sebelum memberikanpengesahan pelulusan untukdistribusi. Penilaian hendaklahmeliputi semua faktor yang relevantermasuk kondisi pembuatan, hasilpengujian <strong>dan</strong>/atau pengawasanselama-proses,pengkajian dokumenproduksi termasuk pengemasan,pengkajian penyimpangan dariprosedur yang telah ditetapkan,pemenuhan persyaratan dariSpesifikasi Produk Jadi <strong>dan</strong>pemeriksaan produk dalam kemasanakhir;g) obat tidak dijual atau didistribusikansebelum kepala Manajemen Mutu(Pemastian Mutu) menyatakanbahwa tiap bets produksi dibuat <strong>dan</strong>dikendalikan sesuai denganpersyaratan yang tercantum dalamizin edar <strong>dan</strong> peraturan lain yangberkaitan dengan aspek produksi,pengawasan mutu <strong>dan</strong> pelulusanproduk;h) tersedia pengaturan yang memadaiuntuk memastikan bahwa, sedapatmungkin, produk disimpan, didistribusikan<strong>dan</strong> selanjutnya ditanganisedemikian rupa agar mutu tetapdijaga selama masa edar/simpanobat;i) tersedia prosedur inspeksi diri<strong>dan</strong>/atau audit mutu yang secaraberkala mengevaluasi efektivitas <strong>dan</strong>penerapan sistem Pemastian Mutu;j) pemasok bahan awal <strong>dan</strong> pengemasdievaluasi <strong>dan</strong> disetujui untukmemenuhi spesifikasi mutu yangtelah ditentukan oleh perusahaan;k) penyimpangan dilaporkan, diselidiki<strong>dan</strong> dicatat;l) tersedia sistem persetujuan terhadapperubahan yang berdampak padamutu produk;m) prosedur pengolahan ulangdievaluasi <strong>dan</strong> disetujui; <strong>dan</strong>n) evaluasi mutu produk berkaladilakukan untuk verifikasi konsistensiproses <strong>dan</strong> memastikan perbaikantesting of each batch of finishedproduct has been reviewed beforeauthorizing release for distribution,assessment should embrace allrelevant factors, includingproduction conditions, results of inprocesstesting, a review ofmanufacturing(including,packaging) documentation anassessment of deviations fromspecified procedures, compliancewith Finished Product Specification,and examination of the finalfinished pack;g) pharmaceutical products are notsold or supplied before the head ofQuality Management (QualityAssurance) has certified that eachproduction batch has beenproduced and controlled inaccor<strong>dan</strong>ce with the requirementsof the marketing authorization an<strong>dan</strong>y other regulations relevant tothe production, control and releaseof pharmaceutical products;h) satisfactory arrangements exist toensure, as far as possible, that thepharmaceutical products arestored, distributed andsubsequently handled so thatquality is maintained throughouttheir shelf life;i) there is a procedure for selfinspection and/or quality auditwhich regularly appraises theeffectiveness and applicability ofthe quality assurance system;j) suppliers of starting materials andpackaging materials are evaluate<strong>dan</strong>d approved to meet thecompany's established qualityspecifications;k) deviations are reported,investigated and recorded;l) there are systems of approvingchanges that may have an impacton product quality;m) reprocessing procedures forproducts are evaluated andapproved; andn) regular evaluations of the quality ofpharmaceutical products areconducted with the objective ofEdisi 2009 - 3 - 2009 Edition

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!